XII Medical Raises $45 Mil in Series B Financing
To advance best-in-class neuromodulation therapy for obstructive sleep apnea.
August 21, 2024
XII Medical Raises $45 Mil in Series B Financing
To advance best-in-class neuromodulation therapy for obstructive sleep apnea.